Project Details
Description
Compare the safety and efficacy of 200 mg PAR-101 Taken q12h with 125 mg Vancomycin taken q6h for ten days in Subjects with clostridium difficile-associated diarrhea
| Status | Finished |
|---|---|
| Effective start/end date | 1/23/07 → 12/31/08 |
Funding
- Optimer Pharmaceuticals, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.